Real-world issues and potential solutions in HCT during the COVID-19 pandemic: Perspectives from the WBMT and the CIBMTR's Health Services and International Studies Committee

The current COVID-19 pandemic, caused by SARS-CoV-2, has impacted many facets of hematopoietic cell transplantation (HCT) in both developed and developing countries. Realizing the challenges as a result of this pandemic affecting the daily practice of the HCT centers, and the recognition of the variability in practice worldwide, the Worldwide Network for Blood& Marrow Transplantation (WBMT) and the Center for International Blood and Marrow Transplant Research (CIBMTR) Health Services and International Studies Committee have jointly produced an expert opinion statement as a general guide to deal with certain aspects of HCT including diagnostics for SARS-CoV-2 in HCT patients, pre-and-post-HCT management, donor issues, medical tourism and facilities management.

Source: Biology of Blood and Marrow Transplantation - July 23, 2020 Category: Hematology Authors: Ghada Algwaiz, Mahmoud Aljurf, Mickey Koh, Mary M. Horowitz, Per Ljungman, Daniel Weisdorf, Wael Saber, Yoshihisa Kodera, Jeff Szer, Dunia Jawdat, William A. Wood, Ruta Brazauskas, Leslie Lehmann, Marcelo C. Pasquini, Adriana Seber, Pei Hua Lu, Yoshiko At Tags: Rapid Publication Source Type: research